BACKGROUND: Transanal endoscopic microsurgery (TEM) is considered a curative option for selected T1 rectal cancer. Although TEM is safe, local recurrence (LR) rates after TEM are unacceptably high. Evidence on selection criteria, however, is not abundant. To expand evidence on low- versus high-risk T1 rectal cancer with respect to LR, this study aimed to identify predictive histopathologic factors in a selected group of T1 rectal cancers treated with TEM only. METHODS: The study enrolled 62 patients for whom specimens of the primary tumor containing an invasive T1 carcinoma could be reevaluated. Tumors were scored according to predefined criteria, and analysis of predictive factors for locoregional failure was performed. RESULT: Local recurrence rates at 3 years for tumors 3 cm in size or smaller were significantly lower than for tumors larger than 3 cm (16 vs. 39%; P < 0.03). Combining smaller tumors with submucosal invasion depth and budding led to identifying tumors that likely will not recur (3-year LR rates, 7 and 10%, respectively). CONCLUSIONS: The findings showed that low- and high-risk criteria are too robust for identifying tumors at risk for LR. Tumor size alone or in combination with submucosal invasion depth or tumor budding appeared to be a significant predictive factor for locoregional failure after TEM for T1 rectal cancer.
BACKGROUND: Transanal endoscopic microsurgery (TEM) is considered a curative option for selected T1 rectal cancer. Although TEM is safe, local recurrence (LR) rates after TEM are unacceptably high. Evidence on selection criteria, however, is not abundant. To expand evidence on low- versus high-risk T1 rectal cancer with respect to LR, this study aimed to identify predictive histopathologic factors in a selected group of T1 rectal cancers treated with TEM only. METHODS: The study enrolled 62 patients for whom specimens of the primary tumor containing an invasive T1 carcinoma could be reevaluated. Tumors were scored according to predefined criteria, and analysis of predictive factors for locoregional failure was performed. RESULT: Local recurrence rates at 3 years for tumors 3 cm in size or smaller were significantly lower than for tumors larger than 3 cm (16 vs. 39%; P < 0.03). Combining smaller tumors with submucosal invasion depth and budding led to identifying tumors that likely will not recur (3-year LR rates, 7 and 10%, respectively). CONCLUSIONS: The findings showed that low- and high-risk criteria are too robust for identifying tumors at risk for LR. Tumor size alone or in combination with submucosal invasion depth or tumor budding appeared to be a significant predictive factor for locoregional failure after TEM for T1 rectal cancer.
Authors: Elizabeth I Harris; David N Lewin; Hanlin L Wang; Gregory Y Lauwers; Amitabh Srivastava; Yu Shyr; Bashar Shakhtour; Frank Revetta; Mary K Washington Journal: Am J Surg Pathol Date: 2008-12 Impact factor: 6.394
Authors: Martin R Weiser; Ron G Landmann; W Douglas Wong; Jinru Shia; José G Guillem; Larissa K Temple; Bruce D Minsky; Alfred M Cohen; Philip B Paty Journal: Dis Colon Rectum Date: 2005-06 Impact factor: 4.585
Authors: Charles M Friel; John W Cromwell; Claudio Marra; Robert D Madoff; David A Rothenberger; Julio Garcia-Aguílar Journal: Dis Colon Rectum Date: 2002-07 Impact factor: 4.585
Authors: S Rasheed; D M Bowley; O Aziz; P P Tekkis; A E Sadat; T Guenther; M L Boello; P J McDonald; I C Talbot; J M A Northover Journal: Colorectal Dis Date: 2008-03 Impact factor: 3.788
Authors: Ernst J Kuipers; William M Grady; David Lieberman; Thomas Seufferlein; Joseph J Sung; Petra G Boelens; Cornelis J H van de Velde; Toshiaki Watanabe Journal: Nat Rev Dis Primers Date: 2015-11-05 Impact factor: 52.329
Authors: Young Seob Shin; Yong Sik Yoon; Seok-Byung Lim; Chang Sik Yu; Tae Won Kim; Heung Moon Chang; Jin-Hong Park; Seung Do Ahn; Sang-Wook Lee; Eun Kyung Choi; Jin Cheon Kim; Jong Hoon Kim Journal: Radiat Oncol J Date: 2016-09-28
Authors: Michael Amann; Ali Modabber; Jens Burghardt; Christian Stratz; Claudius Falch; Gerhard F Buess; Andreas Kirschniak Journal: World J Surg Oncol Date: 2012-11-26 Impact factor: 2.754